HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

67-kDa laminin receptor increases cGMP to induce cancer-selective apoptosis.

Abstract
The 67-kDa laminin receptor (67LR) is a laminin-binding protein overexpressed in various types of cancer, including bile duct carcinoma, colorectal carcinoma, cervical cancer, and breast carcinoma. 67LR plays a vital role in growth and metastasis of tumor cells and resistance to chemotherapy. Here, we show that 67LR functions as a cancer-specific death receptor. In this cell death receptor pathway, cGMP initiated cancer-specific cell death by activating the PKCĪ“/acid sphingomyelinase (PKCĪ“/ASM) pathway. Furthermore, upregulation of cGMP was a rate-determining process of 67LR-dependent cell death induced by the green tea polyphenol (-)-epigallocatechin-3-O-gallate (EGCG), a natural ligand of 67LR. We found that phosphodiesterase 5 (PDE5), a negative regulator of cGMP, was abnormally expressed in multiple cancers and attenuated 67LR-mediated cell death. Vardenafil, a PDE5 inhibitor that is used to treat erectile dysfunction, significantly potentiated the EGCG-activated 67LR-dependent apoptosis without affecting normal cells and prolonged the survival time in a mouse xenograft model. These results suggest that PDE5 inhibitors could be used to elevate cGMP levels to induce 67LR-mediated, cancer-specific cell death.
AuthorsMotofumi Kumazoe, Kaori Sugihara, Shuntaro Tsukamoto, Yuhui Huang, Yukari Tsurudome, Takashi Suzuki, Yumi Suemasu, Naoki Ueda, Shuya Yamashita, Yoonhee Kim, Koji Yamada, Hirofumi Tachibana
JournalThe Journal of clinical investigation (J Clin Invest) Vol. 123 Issue 2 Pg. 787-99 (Feb 2013) ISSN: 1558-8238 [Electronic] United States
PMID23348740 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Imidazoles
  • Phosphodiesterase 5 Inhibitors
  • Piperazines
  • Receptors, Laminin
  • Sulfones
  • Triazines
  • Vardenafil Dihydrochloride
  • Catechin
  • epigallocatechin gallate
  • Cyclic Nucleotide Phosphodiesterases, Type 5
  • Caspases
  • Cyclic GMP
Topics
  • Animals
  • Apoptosis (drug effects, physiology)
  • Caspases (metabolism)
  • Catechin (analogs & derivatives, pharmacology)
  • Cell Line, Tumor
  • Cell Proliferation (drug effects)
  • Cyclic GMP (metabolism)
  • Cyclic Nucleotide Phosphodiesterases, Type 5 (metabolism)
  • Female
  • Humans
  • Imidazoles (pharmacology)
  • Male
  • Membrane Potential, Mitochondrial (drug effects)
  • Mice
  • Mice, Inbred BALB C
  • Molecular Weight
  • Multiple Myeloma (drug therapy, metabolism, pathology)
  • Neoplasms (drug therapy, metabolism, pathology)
  • Phosphodiesterase 5 Inhibitors (pharmacology)
  • Piperazines (pharmacology)
  • Receptors, Laminin (chemistry, metabolism)
  • Signal Transduction
  • Sulfones (pharmacology)
  • Triazines (pharmacology)
  • Vardenafil Dihydrochloride
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: